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Objective: We have previously reported that interleukin-1b (IL-1b) up-regulates the expression of Wnt-
5A and the activation of Wnt-5A signaling induces matrix metalloproteinase (MMP) through the c-Jun
N-terminal kinase pathway in condylar chondrocytes (CCs) of the temporomandibular joint (TMJ). These
results suggest that Wnt-5A could play an essential role in IL-1b-mediated cartilage destruction. The
objective of this study was to investigate the molecular mechanism underlying IL-1b-induced up-
regulation of Wnt-5A in TMJ CCs.
Methods: PrimaryCCs, limb chondrocytes (LCs) and SW1353human chondrosarcoma cellswere treatedwith
IL-1b in the presence or absent of BAY 11-7082 (an inhibitor of IkBa-phosphorylation). Then, expression of
Wnt-5A was estimated by real-time reverse transcriptase-polymerase chain reaction (RT-PCR), Western
blotting and immunocytoﬂuorescence. Transient transfection of p65 expression vector and chromatin
immunoprecipitation (ChIP) assay was performed to deﬁne the effect of p65 on Wnt-5A expression.
Results: IL-1b up-regulated Wnt-5A expression at both the RNA and protein levels in articular chon-
drocytes. The inhibitor of IkBa-phosphorylation, BAY 11-7082, blocked the induction of Wnt-5A by IL-1b
in a dose-dependent manner. Moreover, experiments with overexpression of p65 and ChIP established
that induction of Wnt-5A by IL-1b is mediated through the NF-kB pathway, especially the p65 subunit.
Conclusion: These results clarify the molecular mechanism underlying up-regulation of Wnt-5A by IL-1b
in chondrocytes, suggesting an important functional crosstalk between Wnt-5A and NF-kB signaling
pathways. This ﬁnding provides new insights into the involvement of Wnt signaling in the cartilage
destruction caused by arthritis.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The maintenance of homeostasis in articular cartilage is crucial
for the integrity of its structure and function. The ﬁne balance
betweenmatrix destruction and repair is regulated by catabolic and
anabolic activities of the chondrocytes. In osteoarthritis (OA), this
balance is disturbed and tilted towardmatrix catabolism, leading to
progressive degradation of cartilage1,2.: Xu-Chen Ma or Juan-Hong




s Research Society International. PNumerous studies have revealed that interleukin-1b (IL-1b)
plays a pivotal role in cartilage destruction during the pathophys-
iological process of OA by promoting the release of matrix degen-
erative enzymes and inhibiting the synthesis of extracellular matrix
proteins by chondrocytes1. IL-1b also contributes to the pathogen-
esis of OA by enhancing the expression of other catabolic cytokines3
and by inducing apoptosis of chondrocytes via overproduction of
nitric oxide4. Multiple pathways, including the NF-kB pathway,
are involved in IL-1b’s modulation target gene transcription.
Mammalian NF-kB is a set of dimeric DNA binding proteins whose
subunits include RelA (p65), c-Rel, RelB, NF-kB1 (p50/p105), and
NF-kB2 (p52/p100). NF-kB proteins are capable of forming
numerous homodimers or heterodimers (for example p65ep50) in
complexes with inhibitory IkB and other family members in the
cytoplasm. Upon stimulation by cytokines, chemokines and growthublished by Elsevier Ltd. All rights reserved.
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degradation. In turn, dimeric NF-kB transcription factors, mainly
p65ep50, are enabled to translocate to the nucleus to induce target
gene expression5,6.
Wnt proteins constitute a large family of secreted glycoprotein
ligands that are responsible for important developmental processes
and they have been increasingly implicated in adult tissue
homeostasis and disease processes7. The mammalian genome
encodes 19 Wnt proteins and 10 Frizzled (Fz) seven-pass trans-
membrane receptors. Historically, Wnt proteins have been divided
into “canonical” and “noncanonical” classes, which activate b-cat-
enin-dependent and -independent signaling pathways, respec-
tively (see Wnt-homepage: http://www.stanford.edu/wrnusse/
wntwindow.html). Recently, the traditional classiﬁcation has been
challenged, as it is clear that the pathway activated by a Wnt iso-
form can be highly dependent on cellular context and factors such
as the complement of cell surface Wnt receptors8,9.
There is accumulating evidence for a crucial role of Wnt
signaling in joint development and postnatal joint homeostasis and
remodeling, which points toward a possible association between
Wnt signaling and OA10e12. A previous study from our group also
showed that Wnt signaling may be involved in the destruction of
temporomandibular joint (TMJ) condylar cartilage after experi-
mentally-induced OA13.
Wnt-5A is a representative ligand that activates the b-catenin-
independent pathway in Wnt signaling, which has been known
to regulate chondrogenesis and cartilage development by
promoting chondrocyte differentiation and inhibiting chondrocyte
maturation14e16. Wnt-5A has been associated with rheumatoid
arthritis by induction of some pro-inﬂammation cytokines/che-
mokines in ﬁbroblaste-like synoviocytes17,18. Although positive
expression of Wnt-5A was detected in the articular cartilage of
OA19, the roles of the Wnt ligand in OA have not been well char-
acterized. Recently, several studies have shown that Wnt-5A was
involved in IL-1b-induced matrix metalloproteinase (MMP)
expression and chondrocyte dedifferentiation in TMJ condylar
chondrocytes (CCs) and limb joint chondrocytes, suggesting that
Wnt-5A might be involved in cartilage destruction20,21. While the
up-regulation of Wnt-5A by IL-1b has been reported in chon-
drocytes in several studies, the mechanism underlying up-regula-
tion ofWnt-5A by IL-1b remains unknown. In the present study, we
explored whether up-regulation of Wnt-5A by IL-1b was induced
through the NF-kB pathway in the TMJ CCs.
Materials and methods
Cell cultures and treatments
CCswere isolated fromTMJ condyles of 2-week-old NewZealand
white rabbits (BAOLA, Beijing, China) as described previously21.
Limb chondrocytes (LCs) were isolated from the hyaline cartilage
of hip and shoulder joints by digestion with 0.25% trypsin (Sigma,
St. Louis, MO) for 30 minutes (min), followed by digestionwith 0.2%
collagenase type II (Invitrogen, San Diego, CA) for 4e6 hours (h).
Human chondrosarcoma cells (SW1353) were purchased from the
American Type Culture Collection (ATCC, Rockville, MD). All cells
were cultured in 1:1 mix of Dulbecco’s modiﬁed Eagle’s medium
and Ham’s F12 Nutrient Mix (DMEM/F12; Gibco, Grand Island, NY)
containing 10% fetal bovine serum (Hyclone, Logan, UT), supple-
mented with 50 units of penicillin/streptomycin.
For cell treatment, cells at 80e90% conﬂuencewere washedwith
phosphate buffered saline (PBS) andwere further cultured in serum-
free media overnight. IL-1b (10 ng/ml; Sigma) or Wnt-5A (200 ng/
ml; R&D Systems,Minneapolis, MN)was added into themedia alone
or in combinationwith the speciﬁc inhibitorof IkBaphosphorylation,BAY 11-708222 (Calbiochem, La Jolla, CA). The concentrations of IL-1b
andWnt-5A used were based on our previous study21.
RNA isolation and real-time reverse transcriptase-polymerase chain
reaction (RT-PCR)
Total RNA was isolated with a Total RNA Isolation kit (SBS
Genetech, Beijing, China) according to the manufacturer’s instruc-
tions and digested with RQ1 RNase-free DNase (Promega, Madison,
WI) to remove possible genomic DNA contamination prior to
reverse transcription with Moloney murine leukemia virus RT
(Invitrogen) for 60 min at 42 C. Real-time PCR was performed
using a 7300 Real-time PCR system (Applied Biosystems, Foster
City, CA) and SYBR Green Master Mix (Applied Biosystems). The
primers used for real-time RT-PCR were as follows: for rabbit Wnt-
5A, forward 50-GTATCAGGACCACATGCAGTACATC-30 and reverse
50-GGAACTGATACTGGCATTCTTTGA-30, for humanWnt-5A, forward
50-TAAGCCCAGGAGTTGCTTTG-30 and reverse 50-GCAGAGAGGCTG
TGCTCCTA-3023, and for the internal control 18S RNA, forward
50-GTAACCCGTTGAACCCCATT-30 and reverse 50-CCATCCAATCGG
TAGTAGCG-30. All real-time RT-PCRs were performed in triplicate,
and the ampliﬁcation signal from the target gene was normalized
to the 18S RNA signal in the same reaction. The results were
analyzed using the 2DDCt method as earlier described24.
Western blotting
Cells were lysed with 2% sodium dodecyl sulfate (SDS) lysis
buffer (50 mM Tris-HCl, pH 7.4, 2 mM EDTA, 2% SDS) supplemented
with protease inhibitor cocktail set I (Calbiochem, La Jolla, CA) and
phenylmethanesulfonyl ﬂuoride (PMSF, Sigma). The protein
concentration was determined by the bicinchoninic acid method
using a BCA Protein Assay Kit (Pierce, Rockford, IL). Proteins (50 mg)
were fractionated by SDS-polyacrylamide gel electrophoresis and
transferred onto a nitrocellulose membrane. The membrane was
blocked with 5% nonfat dry milk in Tris-buffered saline containing
0.1% Tween 20. Goat-anti-Wnt-5A (1:1000 dilution, R&D Systems),
rabbit anti-p65 (1:1000 dilution, Santa Cruz Biotechnology, Santa
Cruz, CA) and mouse anti-p-IkBa (1:500 dilution, Santa Cruz
Biotechnology) antibodies were used to detect the proteins. The
blots were developed using a horseradish peroxidase-conjugated
secondary antibody and enhanced chemiluminescence detection.
Immunocytoﬂuorescence
Cells were cultured on glass coverslips and ﬁxed with cold 50%
methanol/50% acetone at 4 C for 15 min. The cells were per-
meabilized with 0.1% Triton X-100 for 10 min three times and
blocked with 5% bovine serum albumin in PBS for 30 min. The cells
were then incubated with goat-anti-Wnt-5A antibody (1:60 dilu-
tions, R&D Systems) at 4 C overnight, followed by ﬂuorescein
isothiocyanate-conjugated secondary antibodies for 1 h. The nuclei
were counterstained with Hoechst 33342 in PBS for 5 min. The
coverslips were mounted on slides with 70% glycerol in PBS and
examined with an Olympus FV1000 confocal microscope.
Transfection experiments
Themammalian expression vector for NF-kB p65 (pRK-p65) was
a generous gift from Dr. Hongbing Shu (Wuhan University College
of Life Science, Wuhan, China)25. The primary CCs, LCs and SW1353
cells at 80e90% conﬂuence were transfected with the vectors using
Vigofect (Vigorous, Beijing, China), which is a mixture of non-lipid
cations, according to the manufacturer’s instructions. Transfected
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further analyses.Luciferase assay
To conﬁrm the suppressive effect of BAY 11-7082 on NF-kB
activity, CCs growing in 24-well tissue culture plates were trans-
fected with the NF-kB-Luc reporter plasmid for 6 h without serum
and then incubated in complete DMEM/F12 for 24 h; they were
then treated with different concentrations of BAY 11-7082 for
another 24 h. To assay the effectiveness of overexpression of p65,
CCs were cotransfected with NF-kB-Luc and pRK-p65 and then
incubated in complete DMEM/F12 for 48 h. Transfection efﬁciency
was normalized by cotransfection with 10 ng pRL-Renilla. Cells
were harvested in 120 ml of Reporter Lysis Buffer (Vigorous), and
activities of the ﬁreﬂy luciferase and the control Renilla luciferase
were simultaneously assayed as described in the dual luciferase
reporter assay system (Vigorous). Fireﬂy luciferase activity was
normalized to the Renilla luciferase activity.Chromatin immunoprecipitation (ChIP) assay
ChIP experiments were performed in SW1353 cells essentially
as described previously26e28. The NF-kB p65 antibody (Santa Cruz
Biotechnology) was used for the immunoprecipitation of cross-Fig. 1. Up-regulation of Wnt-5A by IL-1b in chondrocytes. (A) Wnt-5A mRNA was increa
chondrosarcoma cells after treatment with IL-1b (10 ng/ml) for 24 h. The Wnt-5A mRNA exp
of three independent experiments. (B) The expression of Wnt-5A in CCs and LCs was analyze
immunoﬂuorescence staining for Wnt-5A protein in CCs and SW1353 signiﬁcantly increaselinked chromatin. Primers used for the ampliﬁcation of the Wnt-
5A promoter were as follows: primer 1, 50-AATAAAGGTTTGTGG
TTGGGTA-30 (forward) and 50-AAGGCAGTTCGTGTAGAGGAT-30
(reverse); primer 2, 50-AAGGTCTTTTGCACAATCACG-30 (forward)
and 50-CGCAGGCA ACTGTTCCAC-30 (reverse); and primer 3, 50-
CCAGCAAATGGGACTCGG-30 (forward) and 50-AAGCGGGAAAG
CAACACT-30 (reverse).Enzyme-linked immunosorbent assay (ELISA)
The culture media from the primary CCs were collected after the
cells were treated with Wnt-5A for 12, 24 or 48 h, centrifuged at
2000g for 10 min to discard the debris, and stored at 70 C until
use. IL-1b and MMP-1 were detected in the supernatants using the
ELISA kit for IL-1b (Junyao Biotechnology, Beijing, China) or for
MMP-1 (ESBLab, Sacramento, CA), according to the manufacturer’s
instructions.Statistical analysis
All experiments were repeated three times with independent
cultures and similar results were obtained. Data are presented as
the mean and 95% conﬁdence interval (CI). Statistical signiﬁcance
was determined by the two-tailed unpaired Student’s t-test.
P values less than 0.05 were considered signiﬁcant.sed in CCs from rabbit TMJ, LCs from shoulder and hip joints and SW1353 human
ression was determined by real-time RT-PCR. Data presented were the mean and 95% CI
d byWestern blotting after treatment with IL-1b (10 ng/ml) for 48 h. (C) The intensity of
d after treatment with IL-1b for 24 h (Scale bar¼ 50 mm). Con¼ control.
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Up-regulation of Wnt-5A by IL-1b in CCs
Induction of Wnt-5A expression in response to IL-1b stimuli was
observed in the primary CCs from TMJ and in the primary LCs by
real-time RT-PCR and Western blotting [Fig. 1(A, B)]. The up-regula-
tionofWnt-5AmRNAexpression by IL-1bwas also shown inSW1353
human chondrosarcoma cells by real-time RT-PCR [Fig. 1(A)].
Immunocytoﬂuorescence showed that the Wnt-5A immunos-
taining was signiﬁcantly increased in the cytoplasm of the CCs and
SW1353 cells after treatment with IL-1b for 24 h, showing the
concordance of the effect of both the mRNA and protein levels
[Fig. 1(C)].Blocking IL-1b induction of Wnt-5A with IkBa phosphorylation
inhibitor
To explore whether the NF-kB pathway was involved in the
induction of Wnt-5A by IL-1b, the primary chondrocytes were
treated with IL-1b in the presence of a highly speciﬁc pharmaco-
logic inhibitor of IkBa phosphorylation (BAY 11-7082). The efﬁcacy
of BAY 11-7082 was conﬁrmed with an NF-kB-dependent luciferase
reporter assay [Fig. 2(A)] or by examining the phosphorylation of
IkBa with Western blotting analysis [Fig. 2(B)]. The induction of
Wnt-5A expression by IL-1b in CCs and LCs was dose-dependently
blocked by the IkBa speciﬁc inhibitor determined by real-time RT-
PCR and Western blotting [Fig. 2(C, D)]. Similar results were also
observed in SW1353 cells [Fig. 2(C)].Fig. 2. Blocking IL-1b induction of Wnt-5A with IkBa phosphorylation inhibitor. (A) The su
reporter assay. (B) The efﬁcacy of BAY 11-7082 was conﬁrmed by examining the phosphoryla
the induction of Wnt-5A by IL-1b in chondrocytes. CCs, LCs and SW1353 cells were stimulate
solvent control. Wnt-5A mRNAwas analyzed by real-time RT-PCR. (D) The expression of Wnt
(10 ng/ml) for 48 h. Data presented were the mean and 95% CI of three independent experInduction of Wnt-5A expression by overexpression of NF-kB p65
To further conﬁrm the involvement of NF-kB in the induction of
Wnt-5A by IL-1b, the primary chondrocytes were transiently
transfected with a vector containing the NF-kB p65 gene. The
transfection efﬁciency for primary chondrocytes with Vigofect was
conﬁrmed using a green ﬂuorescence protein (GFP)-containing
plasmid [Fig. 3(A)]. The effectiveness of p65 transfection was
conﬁrmed by luciferase assay [Fig. 3(B)]. Real-time RT-PCR and
Western blotting results showed that overexpression of p65 in CCs
and LCs signiﬁcantly induced Wnt-5A expression compared with
transfection of an empty vector [Fig. 3(C, D)]. Similar results were
also observed in SW1353 cells [Fig. 3(C)].
Recruitment of NF-kB p65 to Wnt-5A promoter after IL-1b
treatment
According to the sequences of the Wnt-5A promoter in human,
mouse and rat, there is a conserved NF-kB p65 binding consensus
located 50 bp upstream of the transcription start site of Wnt-5A in
all three species [Fig. 4(A)]. To examine whether p65 could be
recruited to the promoter of Wnt-5A after IL-1b stimuli, a ChIP
assay was conducted in SW1353 cells treated with IL-1b for 90 min.
The results showed that p65 could directly bind to the Wnt-5A
promoter after IL-1b treatment [Fig. 4(B)].
IL-1b secretion not affected by Wnt-5A in CCs
To investigate whether there was positive feedback between
Wnt-5A and IL-1b, the level of IL-1bwas determined by ELISA in theppressive effect of BAY 11-7082 on NF-kB activity was conﬁrmed with an NF-kB-Luc
tion of IkBawith Western blotting analysis. (C) BAY 11-7082 dose-dependently blocked
d with IL-1b (10 ng/ml) for 24 h in the presence of BAY 11-7082 or dimethyl sulfoxide as
-5A protein in CCs and LCs was analyzed by Western blotting after treatment with IL-1b
iments. *¼ comparison vs “0 mM”.
Fig. 3. Induction of Wnt-5A expression by overexpression of NF-kB p65. (A) The transfection efﬁciency for primary CCs with VigFect was conﬁrmed using a GFP-containing plasmid.
The image was taken 48 h after trasfection. (B) The effectiveness of overexpression of p65 was conﬁrmed by luciferase assay after cotransfection of pRK-p65 and NF-kB-Luc. (C) CCs of
TMJ, LCs and SW1353 cells were transfected with empty vectors or vectors containing p65 (pRK-p65). Wnt-5A expression was analyzed by real-time RT-PCR. (D) The protein levels of
p65 and Wnt-5A after transfection of pRK-p65 in CCs and LCs were determined by Western blotting. Data presented were the mean and 95% CI of three independent experiments.
Fig. 4. Recruitment of NF-kB p65 to Wnt-5A promoter after IL-1b treatment. (A) The
consensus binding sequence for NF-kB (TTAGGGCTTTCCA) is located 50 bp upstream of
the transcription start site of the Wnt-5A promoter (top). The binding sequence for NF-
kB in the Wnt-5A promoter is conserved (bottom). (B) ChIP analysis showed that p65
could be recruited to the Wnt-5A promoter after treatment with IL-1b (10 ng/ml) for
90 min (Primer 2). ChIP analysis with control primers against distinct promoter regions
revealed no recruitment of p65 (Primer 1 and Primer 3). Input¼ chromatin input
before immunoprecipitation, Anti-p65¼ immunoprecipitated chromatin with anti-
p65 antibody, IgG¼ immunoprecipitated chromatin with control IgG.
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times. MMP-1 in the culture media, which served as the positive
control, increased time-dependently after treatment with Wnt-5A.
In contrast, IL-1b in the culture media was not affected by the
treatment with Wnt-5A (Table I).
Discussion
In the present study, we showed that the induction of Wnt-5A
expression by IL-1b in chondrocyteswasmediated through theNF-kB
pathway. To the best of our knowledge, this is the ﬁrst report to
demonstrate that the NF-kB pathway is involved in IL-1b induction
of Wnt-5A in chondrocytes. We are also the ﬁrst to demonstrate that
IL-1b could induce Wnt-5A expression in human chondrosarcoma
cells (SW1353). AlthoughWnts are secreted proteins, the cytoplasmic
staining for Wnt-5A in the SW1353 cells is clear, which could be
explained by that SW1353 is a chondrosarcoma cell line, and up-
regulation of Wnt-5A expression has been associated with various
cancers with clear cytoplasmic Wnt-5A staining29,30. Further experi-
ments are needed to conﬁrmthe expressionofWnt-5A in thecell line.
NF-kB has been shown to play a crucial role in the process of OA,
leading to cartilage destruction and articular damage31. In articular
chondrocytes, NF-kB activation mediates responses to important
proinﬂammatory cytokines [for example, IL-1b and tumor necrosisTable I
The levels of MMP-1 and IL-1b in the culture media were determined by ELISA after
treatment with Wnt-5A (200 ng/ml) for different times. Data presented were the





Absorbance (A) P-value Absorbance (A) P-value
0 0.15 (0.12, 0.18) e 0.13 (0.03, 0.22) e
12 0.20 (0.13, 0.28) 0.0463 0.14 (0.05, 0.23) 0.6682
24 0.24 (0.17, 0.32) 0.0105 0.12 (0.10. 0.15) 0.7658
48 0.28 (0.16, 0.39) 0.0098 0.12 (0.09, 0.15) 0.7184
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drocyte speciﬁc genes (collagen type II, link protein gene)32, and an
increase in the expression of MMPs (MMP-1, MMP-3, MMP-13)33,
cytokines (IL-6, IL-8) and chemokines34. NF-kB is also involved in the
regulation of apoptosis in articular chondrocytes, primarily exerting
anti-apoptosis effects31,35. In the current study, we showed that BAY
11-7082, a speciﬁc inhibitor of IkBa-phosphorylation, abrogated the
induction of Wnt-5A by IL-1b. Indeed, the inhibitor also blocks the
up-regulation of Wnt-5A by TNF-a in human macrophages22.
Furthermore, activation of NF-kB by overexpression of p65 up-
regulated the expression ofWnt-5A and p65 could be recruited to the
promoter ofWnt-5A after IL-1b treatment. These results suggest that
Wnt-5A may be an essential target of NF-kB activation in
chondrocytes.
There is an abundance of data from developmental and cellular
models suggesting that the Wnt signaling pathway may interact
with several other pathways, such as the bone morphogenetic
protein (BMP) pathway, Hedgehog (Hh) pathway, Notch pathway
and ﬁbroblast growth factor (FGF) pathway36. Several studies have
also demonstrated that NF-kB could interplay with b-catenin and
GSK-3b, two key components of the canonical Wnt signaling
pathway37e41. In addition to these studies, we have provided data in
this study to show an important functional crosstalk betweenWnt-
5A and NF-kB signaling pathways in chondrocytes.
AlthoughWnt-5A has been shown to stimulate the release of IL-
1b in human macrophages42, our results showed that the release of
IL-1b was not inﬂuenced by Wnt-5A in the CCs. Therefore, Wnt-5A
promoting the release of IL-1b might be in a cell-type speciﬁc
manner.
In conclusion, we have shown that the induction of Wnt-5A
expression by IL-1b is through the NF-kB pathway in chondrocytes,
suggesting an important functional crosstalk between Wnt-5A and
NF-kB signaling pathways. This result provides new insight into the
involvement of Wnt signaling in the destruction of cartilage in
arthritis.
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